<?xml version="1.0" encoding="UTF-8"?>
<p>The events of 11 September 2001 prompted renewed national efforts for emergency preparedness and response. In addition to funds for biodefense, the U.S. Department of Health and Human Services issued $175 million to assist in preparedness for an influenza pandemic [
 <xref rid="B18-tropicalmed-04-00132" ref-type="bibr">18</xref>]. There was elevated concern for this due to the high case fatality rate in avian to human transmitted influenza A/H5N1 cases and the global spread of highly pathogenic avian H5N1 influenza virus. In 2006, as part the national Pandemic Influenza Plan [
 <xref rid="B19-tropicalmed-04-00132" ref-type="bibr">19</xref>], NYS released its Pandemic Influenza Plan [
 <xref rid="B20-tropicalmed-04-00132" ref-type="bibr">20</xref>] to guide public health officials and health care providers in preparedness and response to a potential influenza pandemic. One of the thirteen sections in this plan addressed the need for rapid and accurate laboratory testing of emerging influenza virus strains that may cause a pandemic. 
</p>
